What are the best preventive medications for an adult patient with a history of frequent or severe migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Preventive Medications for Migraines

For adults with frequent or severe migraines requiring preventive therapy, propranolol (80-240 mg/day) or timolol (20-30 mg/day) are the strongest first-line options, with topiramate (50-100 mg/day) and candesartan as equally effective alternatives based on the most recent guidelines. 1

When to Initiate Preventive Therapy

Preventive therapy should be started when patients meet any of these criteria:

  • Two or more migraine attacks per month with disability lasting 3 or more days 1
  • Using acute medications more than twice per week, which creates risk for medication-overuse headache 1
  • Contraindications to or failure of acute treatments 1
  • Uncommon migraine conditions such as hemiplegic migraine, migraine with prolonged aura, or migrainous infarction 1

First-Line Preventive Medications

Beta-Blockers (Strongest Evidence)

  • Propranolol 80-240 mg/day has the strongest evidence with FDA approval and consistent efficacy data 1
  • Timolol 20-30 mg/day is equally effective with strong evidence 1
  • Alternative beta-blockers include atenolol, bisoprolol, or metoprolol, though with slightly less robust evidence 1
  • Avoid beta-blockers in patients with asthma, bradycardia, or those who practice competitive sports 2

Topiramate

  • Topiramate 50-100 mg/day (typically 50 mg twice daily) is FDA-approved with strong efficacy evidence 1
  • Particularly beneficial for patients with comorbid obesity due to associated weight loss 1
  • Common adverse effects include cognitive slowing, paresthesias, and kidney stones 3

Candesartan

  • Candesartan is a first-line agent especially useful for patients with comorbid hypertension 1
  • Provides dual benefit of blood pressure control and migraine prevention 1

Second-Line Preventive Medications

Amitriptyline

  • Amitriptyline 30-150 mg/day is the most effective antidepressant for migraine prevention 1
  • Optimal choice for patients with mixed migraine and tension-type headache, or comorbid depression/anxiety/insomnia 1, 4
  • Start low (10-25 mg at bedtime) and titrate slowly to minimize anticholinergic side effects 1

Valproate/Divalproex

  • Sodium valproate 800-1500 mg/day or divalproex sodium 500-1500 mg/day are highly effective 1
  • Strictly contraindicated in women of childbearing potential due to teratogenic effects 1, 3
  • Adverse effects include weight gain, hair loss, tremor, and hepatotoxicity 1

Third-Line: CGRP Monoclonal Antibodies

  • Erenumab, fremanezumab, or galcanezumab should be considered when 2-3 oral preventive medications have failed or are contraindicated 1
  • Administered monthly via subcutaneous injection 1
  • Require 3-6 months for adequate efficacy assessment, significantly longer than oral agents 1
  • Significantly more expensive ($5,000-$6,000 annually) than oral preventives 1
  • Eptinezumab (IV) and atogepant (oral) have weaker evidence 1

OnabotulinumToxinA (Botox)

  • Recommended ONLY for chronic migraine (≥15 headache days per month), NOT for episodic migraine 1
  • Specifically recommended AGAINST for episodic migraine prevention 1
  • Requires 6-9 months for adequate efficacy assessment 1
  • Serious risks include spread of toxin effects causing botulism-like symptoms, swallowing/breathing problems, and potential death 5

Implementation Strategy

Titration and Trial Period

  • Start with low doses and titrate slowly until clinical benefits are achieved or side effects limit further increases 1
  • Allow 2-3 months for adequate trial of oral preventive medications before determining efficacy 1
  • Use headache diaries to track attack frequency, severity, duration, and treatment response 1

Duration of Therapy

  • Continue successful preventive therapy for 6-12 months before attempting to taper 1
  • After stability period, consider tapering or discontinuing to determine if ongoing treatment is necessary 1
  • Calculate percentage reduction in monthly migraine days to quantify success 1

Critical Pitfalls to Avoid

  • Never allow acute medication use to exceed 2 days per week, as this creates medication-overuse headache that undermines preventive therapy 1, 6
  • Do not abandon a preventive medication before completing adequate trial period: 2-3 months for oral agents, 3-6 months for CGRP antibodies, 6-9 months for onabotulinumtoxinA 1
  • Screen for medication-overuse headache before starting preventive therapy (≥10 days/month for triptans, ≥15 days/month for NSAIDs) 1
  • Do not start with excessively high doses, which leads to poor tolerability and discontinuation 1
  • Verify no contraindications: avoid valproate in women of childbearing potential, beta-blockers in asthmatics, topiramate in patients with kidney stones 1, 3

Non-Pharmacological Adjuncts

  • Cognitive behavioral therapy, biofeedback, and relaxation training should be offered alongside medication as effective adjuncts 1
  • Neuromodulatory devices can be considered when medications are contraindicated 1
  • Identify and modify triggers: sleep hygiene, regular meals, hydration, stress management 1
  • Complementary treatments with probable efficacy include riboflavin, magnesium, feverfew, and petasites 3

References

Guideline

Migraine Prevention Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Prophylactic treatments of migraine].

Revue neurologique, 2000

Research

Migraine Headache Prophylaxis.

American family physician, 2019

Research

Preventive migraine treatment.

Neurologic clinics, 2009

Research

Pharmacological prevention of migraine.

Clinical neuroscience (New York, N.Y.), 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.